scispace - formally typeset
S

Safiye Osman

Researcher at Hammersmith Hospital

Publications -  82
Citations -  5031

Safiye Osman is an academic researcher from Hammersmith Hospital. The author has contributed to research in topics: Radioligand & In vivo. The author has an hindex of 40, co-authored 82 publications receiving 4914 citations. Previous affiliations of Safiye Osman include GE Healthcare & Imperial College London.

Papers
More filters
Journal ArticleDOI

Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies

TL;DR: The reference tissue model provided estimates of the binding potential with the same sensitivity for detecting changes as those methods that required a metabolite-corrected plasma input function, indicating that for routine analysis of clinical [11C]raclopride studies, no arterial cannulation is required.
Journal Article

3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.

TL;DR: The ability to measure tumor response to antiproliferative treatment with [(18)F]FLT and PET and other than phosphorylation in tumors, [(18]F] FLT was found to be metabolically stable in vivo.
Journal ArticleDOI

Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET

TL;DR: It is concluded that a simplified reference tissue approach may be used to quantify 5-HT1A binding either in terms of ROI data or as parametric images.
Journal ArticleDOI

Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635

TL;DR: The acquired data provide exquisite delineation of 5-HT1A receptors in brain, with the ratio of radioactivity uptake in receptor-rich regions, such as medial temporal cortex, to that in receptors-devoid cerebellum reaching 25 by 60 min after radioligand injection.